Your session is about to expire
← Back to Search
Alpha Blockade for Pheochromocytoma
Study Summary
This trial will compare the effects of two different types of drugs used to treat a rare tumor that causes the body to produce too much of the hormone adrenaline.
- Pheochromocytoma
- Paraganglioma
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Group 1: Phenoxybenzamine
- Group 2: Doxazosin
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Approved for 5 Other Conditions - This treatment demonstrated efficacy for 5 other conditions.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has Doxazosin been accepted by the FDA?
"Doxazosin has been evaluated for efficacy in Phase 3 clinical trials and was found to be safe, so it received a score of 3."
Is Doxazosin a common medication in clinical trials?
"There are currently 7 ongoing studies researching Doxazosin with 2 trials in Phase 3. However, there are 36 different locations running clinical trials for Doxazosin--not just Oklahoma City, Oklahoma."
How many test subjects are currently enrolled in this research?
"That is correct, the listing on clinicaltrials.gov indicates that this study is still open to enrolling patients. The trial was created on May 5th, 2017 and has had 60 patients enrolled from 1 location."
Are there any available positions for patients who would like to participate in this trial?
"The clinical trial is currently looking for participants and was originally posted on May 5th, 2017. The study received its last update on September 18th, 2019."
Share this study with friends
Copy Link
Messenger